Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2021 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2021 Volume 21 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis

  • Authors:
    • Chuanxian Hu
    • Su Huang
    • Fafu Wu
    • Hui Ding
  • View Affiliations / Copyright

    Affiliations: Department of Cardiopulmonary Surgery, Huai'an First People's Hospital, Huai'an, Jiangsu 223300, P.R. China
    Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 36
    |
    Published online on: November 11, 2020
       https://doi.org/10.3892/etm.2020.9468
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

MicroRNAs (miRs) play important roles in the protection against and development of congenital heart disease (CHD). However, the role and potential mechanisms of miR‑219‑5p in cyanotic CHD remains unclear. Reverse transcription‑quantitative PCR (RT‑qPCR) was used to measure miR‑219‑5p levels in cyanotic CHD and hypoxia‑induced H9C2 cells. Dual luciferase reporter gene assay was used to confirm whether liver receptor homolog‑1 (LRH‑1) was a direct target of miR‑219‑5p. miR‑219‑5p inhibitor and LRH‑1‑small interfering RNA were transfected into H9C2 cells under hypoxic conditions to investigate the role of miR‑219‑5p in hypoxia‑induced H9C2 cells. Subsequently, cell viability was detected using an MTT assay and cell apoptosis was detected using flow cytometry. In addition, RT‑qPCR and western blotting assays were performed to detect the mRNA and protein expression of LRH‑1, cyclin D1 and β‑catenin, respectively. The data showed that miR‑219‑5p expression was higher in patients with cyanotic CHD compared with patients with acyanotic CHD gradually increased in H9C2 cells with prolonged hypoxia time. Dual luciferase reporter assay results showed that LRH‑1 was a direct target gene of miR‑219‑5p. Inhibition of miR‑219‑5p reversed hypoxia‑induced cell viability reduction and attenuated hypoxia‑induced cell apoptosis. In addition, hypoxia induction inhibited the expression of LRH‑1, cyclin D1 and β‑catenin, which was reversed by miR‑219‑5p inhibitor. However, LRH‑1 downregulation reversed the miR‑219‑5p inhibitor enhanced cell viability, decreased cell apoptosis and increased expression of LRH‑1, cyclin D1 and β‑catenin in hypoxia‑treated cardiomyocytes. The present results demonstrated that downregulation of miR‑219‑5p promoted the expression of the LRH‑1/Wnt/β‑catenin signaling pathway‑associated components, reduced cardiomyocyte apoptosis and increased cell growth under hypoxic conditions. miR‑219‑5p may be a potential therapeutic target for cyanotic CHD therapy.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Cassidy AR, White MT, DeMaso DR, Newburger JW and Bellinger DC: Executive function in children and adolescents with critical cyanotic congenital heart disease. J Int Neuropsychol Soc. 21:34–49. 2015.PubMed/NCBI View Article : Google Scholar

2 

Hoffman JI and Kaplan S: The incidence of congenital heart disease. J Am Coll Cardiol. 39:1890–1900. 2002.PubMed/NCBI View Article : Google Scholar

3 

Haseba S, Sakakima H, Nakao S, Ohira M, Yanagi S, Imoto Y, Yoshida A and Shimodozono M: Early postoperative physical therapy for improving short-term gross motor outcome in infants with cyanotic and acyanotic congenital heart disease. Disabil Rehabil. 40:1694–1701. 2018.PubMed/NCBI View Article : Google Scholar

4 

Cordina RL and Celermajer DS: Chronic cyanosis and vascular function: Implications for patients with cyanotic congenital heart disease. Cardiol Young. 20:242–253. 2010.PubMed/NCBI View Article : Google Scholar

5 

Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004.PubMed/NCBI View Article : Google Scholar

6 

Wang L, Tian D, Hu J, Xing H, Sun M, Wang J, Jian Q and Yang H: miRNA-145 regulates the development of congenital heart disease through targeting FXN. Pediatr Cardiol. 37:629–636. 2016.PubMed/NCBI View Article : Google Scholar

7 

Zhang Y, Peng B and Han Y: miR-182 alleviates the development of cyanotic congenital heart disease by suppressing HES1. Eur J Pharmacol. 836:18–24. 2018.PubMed/NCBI View Article : Google Scholar

8 

Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi L, Liu X, Bai J, Deng M, Shuai X, et al: miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4. Oncol Rep. 34:1923–1932. 2015.PubMed/NCBI View Article : Google Scholar

9 

Jiang Y, Yin L, Jing H and Zhang H: MicroRNA-219-5p exerts tumor suppressor function by targeting ROBO1 in glioblastoma. Tumour Biol. 36:8943–8951. 2015.PubMed/NCBI View Article : Google Scholar

10 

Fayard E, Auwerx J and Schoonjans K: LRH-1: An orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol. 14:250–260. 2004.PubMed/NCBI View Article : Google Scholar

11 

Wang ZN, Bassett M and Rainey WE: Liver receptor homologue-1 is expressed in the adrenal and can regulate transcription of 11 beta-hydroxylase. J Mol Endocrinol. 27:255–258. 2001.PubMed/NCBI View Article : Google Scholar

12 

Grgurevic N, Tobet S and Majdic G: Widespread expression of liver receptor homolog 1 in mouse brain. Neuro Endocrinol Lett. 26:541–547. 2005.PubMed/NCBI

13 

Wu C, Feng J, Li L, Wu Y, Xie H, Yin Y, Ye J and Li Z: Liver receptor homologue 1, a novel prognostic marker in colon cancer patients. Oncol Lett. 16:2833–2838. 2018.PubMed/NCBI View Article : Google Scholar

14 

Bianco S, Jangal M, Garneau D and Gévry N: LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression. Oncogene. 34:4509–4518. 2015.PubMed/NCBI View Article : Google Scholar

15 

Xiao L, Wang Y, Xu K, Hu H, Xu Z, Wu D, Wang Z, You W, Ng CF, Yu S, et al: Nuclear receptor LRH-1 functions to promote castration-resistant growth of prostate cancer via its promotion of intratumoral androgen biosynthesis. Cancer Res. 78:2205–2218. 2018.PubMed/NCBI View Article : Google Scholar

16 

Jian Z, Li JB, Ma RY, Chen L, Zhong QJ, Wang XF, Wang W, Hong Y and Xiao YB: Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia. Clin Chim Acta. 405:132–138. 2009.PubMed/NCBI View Article : Google Scholar

17 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

18 

Piccoli M, Conforti E, Varrica A, Ghiroldi A, Cirillo F, Resmini G, Pluchinotta F, Tettamanti G, Giamberti A, Frigiola A, et al: NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients. Int J Cardiol. 230:6–13. 2017.PubMed/NCBI View Article : Google Scholar

19 

Gong L, Xu H, Chang H, Tong Y, Zhang T and Guo G: Knockdown of long non-coding RNA MEG3 protects H9c2 cells from hypoxia-induced injury by targeting microRNA-183. J Cell Biochem. 119:1429–1440. 2018.PubMed/NCBI View Article : Google Scholar

20 

Park M, Youn B, Zheng XL, Wu D, Xu A and Sweeney G: Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis. PLoS One. 6(e19143)2011.PubMed/NCBI View Article : Google Scholar

21 

Hao P, Cao X, Zhu Z, Gao C, Chen Y and Qi D: Effects of miR-181a targeting XIAP gene on apoptosis of cardiomyocytes induced by hypoxia/reoxygenation and its mechanism. J Cell Biochem: Nov 28, 2018 (Epub ahead of print).

22 

Ma J, Zhang J, Wang Y, Long K, Wang X, Jin L, Tang Q, Zhu L, Tang G, Li X, et al: miR-532-5p alleviates hypoxia-induced cardiomyocyte apoptosis by targeting PDCD4. Gene. 675:36–43. 2018.PubMed/NCBI View Article : Google Scholar

23 

Li J, Li L and Shen Y: Protective role of microRNA-219-5p inhibitor against spinal cord injury via liver receptor homolog-1/Wnt/β-catenin signaling pathway regulation. Exp Ther Med. 15:3563–3569. 2018.PubMed/NCBI View Article : Google Scholar

24 

Yang J, Sheng YY, Wei JW, Gao XM, Zhu Y, Jia HL, Dong QZ and Qin LX: MicroRNA-219-5p promotes tumor growth and metastasis of hepatocellular carcinoma by regulating cadherin 1. BioMed Res Int. 2018(4793971)2018.PubMed/NCBI View Article : Google Scholar

25 

Tang Q and Ran H: MicroRNA-219-5p inhibits wound healing by targeting TMEM98 in keratinocytes under normoxia and hypoxia condition. Eur Rev Med Pharmacol Sci. 22:6205–6211. 2018.PubMed/NCBI View Article : Google Scholar

26 

Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, Wendling O, Tanaka T, Kodama T, Thomas W, Auwerx J, et al: Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell. 15:499–509. 2004.PubMed/NCBI View Article : Google Scholar

27 

Fodde R and Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 19:150–158. 2007.PubMed/NCBI View Article : Google Scholar

28 

Zhao Y, Wang C, Wang C, Hong X, Miao J, Liao Y, Zhou L and Liu Y: An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease. Sci Rep. 8(8996)2018.PubMed/NCBI View Article : Google Scholar

29 

Sun X, Pang L, Shi M, Huang J and Wang Y: HIF2α induces cardiomyogenesis via Wnt/β-catenin signaling in mouse embryonic stem cells. J Transl Med. 13(88)2015.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hu C, Huang S, Wu F and Ding H: MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis. Exp Ther Med 21: 36, 2021.
APA
Hu, C., Huang, S., Wu, F., & Ding, H. (2021). MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis. Experimental and Therapeutic Medicine, 21, 36. https://doi.org/10.3892/etm.2020.9468
MLA
Hu, C., Huang, S., Wu, F., Ding, H."MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis". Experimental and Therapeutic Medicine 21.1 (2021): 36.
Chicago
Hu, C., Huang, S., Wu, F., Ding, H."MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis". Experimental and Therapeutic Medicine 21, no. 1 (2021): 36. https://doi.org/10.3892/etm.2020.9468
Copy and paste a formatted citation
x
Spandidos Publications style
Hu C, Huang S, Wu F and Ding H: MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis. Exp Ther Med 21: 36, 2021.
APA
Hu, C., Huang, S., Wu, F., & Ding, H. (2021). MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis. Experimental and Therapeutic Medicine, 21, 36. https://doi.org/10.3892/etm.2020.9468
MLA
Hu, C., Huang, S., Wu, F., Ding, H."MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis". Experimental and Therapeutic Medicine 21.1 (2021): 36.
Chicago
Hu, C., Huang, S., Wu, F., Ding, H."MicroRNA‑219‑5p participates in cyanotic congenital heart disease progression by regulating cardiomyocyte apoptosis". Experimental and Therapeutic Medicine 21, no. 1 (2021): 36. https://doi.org/10.3892/etm.2020.9468
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team